Vaccine hopes boosted shared, but  entiment was still cautious ahead of a big week of central bank meetings in UK, Japan and the United States.

AstraZeneca announced it has resumed British clinical trials of its COVID-19 vaccine at the weekend, after getting the green light from safety watchdogs.

This is one of the most advanced in development.

The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended last week after an illness in a study subject in Britain, casting doubts on an early rollout.

A vaccine has long been awaited to help pull the world out of a coronavirus-induced lockdown.

“The reopening of the global economy is enticing us to recommend a trade going long a basket of 14 laggard ‘back to work’ stocks versus a basket of 14 high-flying ‘COVID-19 winners’,” BCA Research wrote in a note.

“While we maintain a cyclical and secular bullish outlook on the broad market, a short-term correction due to technical and (geo) political reasons is likely on the cards,” it said

“A playable short-term pullback is in order.”


9.15am update: European markets start strong

Like FTSE, European markets have started the day brightly.

Euronext 100 is up 0.70%, CAC 40 is up 0.77%, DAX is up 0.53% and Swiss Market Index is up 0.30%.

8.20am update: FTSE soars on open

FTSE has soared on open this morning, growing 70 points in just a matter of minutes.

The UK index closed at 6,043 on Friday afternoon, after a productive week during which it rose from 5,799.

This morning the index has continued its bright form, rising from 6,043 to 6,076.

More to follow…



Please enter your comment!
Please enter your name here